Related references
Note: Only part of the references are listed.Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
John D. Isaacs et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
M. Couderc et al.
ARTHRITIS CARE & RESEARCH (2013)
Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
David B. Clifford et al.
ARCHIVES OF NEUROLOGY (2011)
Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
Shigeru Iwata et al.
JOURNAL OF RHEUMATOLOGY (2011)
Cytomegalovirus Colitis and Hypo-IgG After Rituximab Therapy for Rheumatoid Arthritis
Helene Vallet et al.
JOURNAL OF RHEUMATOLOGY (2011)
Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab
Tom Wingfield et al.
RHEUMATOLOGY (2011)
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Heleen Scheerens et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Management of Nonresponse to Rituximab in Rheumatoid Arthritis Predictors and Outcome of Re-treatment
E. M. Vital et al.
ARTHRITIS AND RHEUMATISM (2010)
Progressive Multifocal Leukoencephalopathy Following Rituximab Treatment in a Patient With Rheumatoid Arthritis
R. M. Fleischmann
ARTHRITIS AND RHEUMATISM (2009)
Anti-CD20 therapy in patients with rheumatoid arthritis -: Predictors of response and B cell subset regeneration after repeated treatment
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2008)
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
David Saadoun et al.
BLOOD (2008)
B-lymphocyte contributions to human autoimmune disease
Koichi Yanaba et al.
IMMUNOLOGICAL REVIEWS (2008)
Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis
L. L. Teichmann et al.
RHEUMATOLOGY (2008)
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
R. M. Thurlings et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial
JM Kremer et al.
ARTHRITIS AND RHEUMATISM (2005)
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand - An open-label trial
PP Sfikakis et al.
ARTHRITIS AND RHEUMATISM (2005)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients
EHS Choy et al.
RHEUMATOLOGY (2000)
Share Paper
